WO1990000369A1 - A removable inflatable intragastrointestinal device for delivering beneficial agents - Google Patents
A removable inflatable intragastrointestinal device for delivering beneficial agents Download PDFInfo
- Publication number
- WO1990000369A1 WO1990000369A1 PCT/US1989/002924 US8902924W WO9000369A1 WO 1990000369 A1 WO1990000369 A1 WO 1990000369A1 US 8902924 W US8902924 W US 8902924W WO 9000369 A1 WO9000369 A1 WO 9000369A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stomach
- inflatable member
- inflation tube
- agent
- cartridge
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
Definitions
- the invention is in the field of drug delivery.
- the prolonged delivery of drugs orally has been a major challenge and a long desired objective in drug therapy. This is a favored route for drug administration. It is estimated that 65% of all drugs are ingested. The successful accomplishment of prolonged gastrointestinal drug delivery-, has great therapeutic significance in the treatment of various diseases and conditions.
- the spontaneous expulsion of such a device from the gastrointestinal tract once its active material has been expended is much more of a challenge, however.
- the Michaels device comes equipped with an imbedded bioerodible plug whose object is to assure the balloon's eventual deflation.
- the balloon loses air by being minimally permeable to a gas with which it has been inflated.
- Place and Bashaw, et al disclose in U.S. Patents 3,797,492 and 3,944,064 a variation of the system described above, suggesting that a propellant-charged capsular compartment can keep the device afloat in the stomach and also accomplish the controlled release of the active drug.
- Another drug-dispensing device for the prolonged administration of pharmaceuticals is disclosed in U.S. Patent 4,207,890. This device is made of dual polymer envelopes, one of ; which swells and expands osmotically when the device reaches the stomach, while the other contains the drug and dispenses it at a pre ⁇ determined rate based on the polymer envelope's perme ⁇ ability characteristics.
- Intragastric balloon devices have also been developed for the purpose of appetite control and weight reduction.
- Berman, et al (U.S. 4,133,315) describe a large balloon which is to be introduced deflated into the stomach via a naso-gastric tube.
- the balloon is to be fluid filled with an attached insufflation tube that remains in place and extends through the esophagus and the nasal passages to the outside environment.
- a more advanced concept of this intragastric balloon * weight loss device was disclosed in U.S. Patent 4,485,805.
- This elastomeric rubber balloon was equipped with a self- sealfng valve and its inflator tube could be withdrawn from the stomach, leaving behind the fluid inflated bal ⁇ loon.
- the bal- loon When the desired weight loss is achieved, the bal- loon is to be deflated, and withdrawn from the stomach by endoscopy.
- the Garren-Edwards gastric bubble consists of a self-sealing, cylindrical intragastric balloon which has been made commercially available for weight reduction and appetite control (Endoscopy Review, 1, 57-60, 1984).
- the phenomenon of bio or mucoadhesion with polymeric substances has received considerable attention ( "Advances in Drug Delivery Systems", J.M. Anderson and S.W. Kim, Eds., Elsevier, Amsterdam, Vol. 1, 1986, pp 47-57).
- the temporary and adhesive attachment of prolonged release drug delivery systems to the gastrointestinal mucosa is a novel ap ⁇ proach.
- the various mucoadhesive techniques are still under early experimental investigation.
- Th objective of this invention is to provide a novel device that fulfills these requirements.
- the invention is an inflatable device which is introduced into the lumen of the stomach, and inflated while in the stomach in order to prevent it from progress ing into the lower gastrointestinal tract.
- a beneficial agent-containing cartridge is carried by the device and releases the " agent to the stomach or the intestinal tract.
- the device may include means by which it may be retrieved from the stomach.
- the invention is a removable inflatable intragastrointestinal beneficial agent deliver device adapted to reside within a stomach comprising:
- a hollow inflation tube for inflating the inflatable member one end of which is operably connected to the inflatable member and the other end of which car ⁇ ries a valve, said inflation tube having a length suf ⁇ ficient to extend from the mouth through the esophagus and into the stomach, providing a means by which the inflat ⁇ able member may be inflated from outside the body with an inflation medium, and being adapted to reside within the stomach after the inflatable member is inflated;
- the invention thus provides a removable platform from which drugs or other beneficial agents may be released into the gastrointestinal tract at predetermined doses and dosage regimens.
- the cartridge element(s) of the device is capable of receiving and holding, unit doses of the agent, thus facilitating tailoring the dose, and/or dosage regimen or the administration of a multiplicity of different agents simultaneously or in a predetermined sequence. Further, the cartridge may be designed so that the unit doses can be removed and/or replaced, thus making it possible £o alter or extend administration of the agent(s) at will.
- Fig. 1 is a partly sectional view of an embodiment of the device in its inflated state residing within the stomach.
- Fig. 2 is a partly sectional view of the device of Fig. 1 in its deflated state being placed within the stomach via a naso-gastric tube.
- Fig. 3 is a partly sectional view of the device of Fig. 1 in its inflated state and a syringe for inflat ⁇ ing the device.
- Fig. 4 is a sectional view of a beneficial agent-containing cartridge unit of the device of Fig. 1 taken along line 4-4 of Fig. 3.
- Fig. 5 is a sectional view of another embodiment of the invention device where the cartridges reside within a cavity in the inflatable member of the device.
- drug as used herein broadly includes physiologically and/or pharmacqlogically active substances for producing a local effect within the gastrointestinal tract or a systemic effect at a remote site within the body.
- Figs. 1-4 depict an embodiment of the invention, generally designated 10.
- Device 10 is composed of three principal elements: an inflatable member 11, an inflation tube 12, and a plurality of beneficial agent-containing cartridges 13.
- the inflatable member 11 is sized and shaped so that when deflated it can be inserted into the stomach 14 via a naso-gastric tube 15 (Fig. 2) that extends through the mouth 16 and esophagus 17 and opens into the stomach. Its size and shape in the inflated state (Fig. 1) are suc that it resides comfortably within the stomach without being able to pass through the pyloric sphincter 18. While the inflated shape of member 11 is toroidal it will be appreciated that other shapes such as ovoidal, el ⁇ lipsoidal, spheroidal, triangular, and the like may be employed.
- Shapes that have a central opening allow stomach contents to pass through th pyloric sphincter even if the device settles against the pyloric region of the stomach.
- the volume of the inflated member will normally be 20 to 1,000 cc, preferably 50 to 500 cc.
- Member 11 may be made solely of an elastomeric polymer or be an elastomeric laminated composite of metal foil, polymer or fiber. Member 11 is inflated using hollow inflation tube 12, one end 18 (Fig. 3) of which operably connects into the lumen 19 of the inflatable member and the other end 20 of which carries a valve 21.
- the length of the tube is sufficient to extend through the mouth and esophagus and into the stomach with its end 20 outside the mouth.
- Valve 21 is designed to interconnect with a syringe 22 that may be charged with an inflation medium (either gas or liquid, preferably gas, and most preferably air) .
- Cartridges 13 are strung on inflation tube 12 in bead-like fashion. Referring to Fig. 4, each cartridge has a"n opening 23 through it that receives tube 12, thus enabling the cartridges to be so carried on the tube. It will be appreciated that the cartridges could interfit with, be carried by, or otherwise be affixed to the tube in other manners. As seen in Fig.
- the cartridge may have a monolithic structure composed entirely of an agent (drug) formulation or agent dispersed in a matrix material.
- the cartridges may have a container structure composed of a housing or wall that defines a lumen and an agent formulation within the lumen.
- the wall may be agent- permeable, semipermeable, porous, or bioerodible, depend ⁇ ing upon the nature of the agent release mechanism that is employed.
- the structure and/or composition of the cartridge is preferably such that the release of agent from the cartridge will occur over a sustained period, e.g., from one day to one year.
- a sustained period e.g., from one day to one year.
- Various mechanisms to achieve sustained release such as diffusion, osmosis, bioerosion, swelling, dissolution or combinations thereof may be employed.
- the wall may have pores to permit gastric juice to enter the reservoir and contact the agent or agent- release mechanism within it.
- the wall may be required to be permeable to the agent or be semipermeable to permit gastric fluid to be imbibed into the pocket to effect agent release by an osmotic mechanism.
- the agent may be in the form of a solid, gel, microcapsule, or liquid, depending, again, upon the natur of the cartridge and may be neat or formulated with carri ⁇ ers or diluents. It may be present in the form of a multiplicity of individual dosage units to facilitate tailoring of the dose. Alternatively, a multiplicity of different agents may be contained in the cartridges to achieve multi-agent administration simultaneously or in a predetermined sequence or pattern. By using a multiplicity of unit dosage cartridges, doses may be easily adjusted via the number o cartridges.
- a cartridge may contain more than one agent or when more than one cartridge is employed the individua cartridges may contain different agents.
- the structure o the cartridge and/or the formulation of the agent within the cartridge are preferably such that the release of agent from the cartridge will be over a sustained time period.
- Fig. 2 shows the manner in which device 10 is inserted into the stomach.
- the naso-gastric tube 15 is first inserted through the mouth and esophagus into the stomach.
- the device in its deflated state is then plunged down the tube 15 and into the stomach using a plunger 24.
- the valve end of the trailing inflation tube is left outside of the oral cavity.
- the inflatable member is inflated with the desired inflation medium using a syringe or other infla ⁇ tion device. Once inflated, the size/shape of the inflat ⁇ able member prevents the device from passing through the pyloric sphincter and entering the lower gastrointestinal tract. Finally, the inflation tube and valve are allowed to pass into the stomach.
- the materials used to make the device may include a component that renders one or more elements of the device opaque to radiation, thereby permitting the device to be "seen” by conventional medical imaging devices.
- the device may be left in the stomach from one day to one year for the sustained release of the agent from the cartridges.
- the endoscopist may choose to add and/or remove beneficial agent cartridges once the device has been placed in the stomach. This could be achieved by retriev- ing the valve end of the tube magnetically using a magnetic ring 25 affixed to the valve end of the tube. After the endoscopist locates the valve, it would be magnetically retracted from the stomach, through the esophagus, with the trailing string of beneficial agent - J 0- bearing cartridges. The addition or removal of cartridges could thus be performed.
- the endoscopist may choose to leave the entire inflator valve and its trailing tubing in the stomach for the duration of the therapy, or use a heated endoscopic probe to heat-seal the tube at several points past the drug-bearing cartridges. Then the proximal section of the tube with its attached valve 21 could be cut and removed from the stomach by endoscopic forceps. hen the beneficial agent content of the device has been exhausted and/or if an early or temporary inter ⁇ ruption of the administration is desired, the inflatable member could be either deflated or punctured endoscopically and recovered from the stomach by pulling it through the esophagus into the mouth with endoscopic forceps. An alternative recovery procedure would retrieve the valve end of the inflation tube magnetically and deflate the inflatable member with a syringe, thereby af- fording a smooth withdrawal of the entire device from the gastric lumen.
- Fig. 5 depicts another embodiment of the inven ⁇ tion device, generally designated 26.
- Device 26 differs from device 10 as regards the structure of the inflatable member and the manner in which the agent-containing cartridges are carried.
- Device 26 has an inflatable memb r 27 thit is generally ellipsoidal in shape in its inflated state (shown in Fig. 5) and has an opening or channel 28 extending through it. Opening 28 defines a cavity in which cartridges 13 reside. The ends of the opening are closed by caps 29 which have perforations 30 to permit gastric fluids to flow into and through the opening, thereby contacting cartridges 13.
- the profile of device 26 is essentially that of the cartridge-containing channel. - l l -
Abstract
A removable inflatable beneficial agent delivery device (10) that is adapted to reside in the stomach for a prolonged time period. The device comprises an inflatable member (11) which in its deflated state can be inserted into the stomach via a naso-gastric tube (15) and which in its inflated state resides comfortably in the stomach (16) but cannot pass through the pyloric sphincter, (2) an inflation tube (12) connected to the inflated from outside the body and which is dropped into the stomach after inflation, and (3) one or more agent-containing cartridges (13) that are carried exteriorly on the inflatable member or the inflation tube and are capable of delivering agent to the gastrointestinal tract over a prolonged time period.
Description
A REMOVABLE INFLATABLE INTRAGASTROINTESTINAL DEVICE FOR DELIVERING BENEFICIAL AGENTS
Description
Technical Field The invention is in the field of drug delivery.
More specifically it is in the field of sustained release devices for administering drugs or other beneficial agents within the gastrointestinal tract.
Background of the Invention
The prolonged delivery of drugs orally has been a major challenge and a long desired objective in drug therapy. This is a favored route for drug administration. It is estimated that 65% of all drugs are ingested. The successful accomplishment of prolonged gastrointestinal drug delivery-, has great therapeutic significance in the treatment of various diseases and conditions.
Systemic and transder al sustained drug delivery systems have been developed which are capable of deliver- ing constant amounts of therapeutic substances from several days to several months. The major limitation to long-term oral delivery, however, is the 8-16 hour gastrointestinal transit time of an ingested substance. In order to achieve uninterrupted action for longer than 24 hours by a therapeutic- substance, its passage needs to
be slowed in the gastrointestinal tract or the delivery device supplying the drug has to be fixed or immobilized within the tract.
Attempts have been made either to incorporate drugs into floating devices which would empty less readily from the stomach (N. Eng. J. Med. [1981] 304:1365-1366), or to introduce balloon based devices which could be inflated by propellants or be fluid expanded in the stomach after the whole device had been swallowed. Michaels (U.S. Patents 3,786,813; 3,788,322 and 3,901,232) proposed a series of capsular, swallowable devices. Upon ingestion, the wall of these capsules would erode, releas¬ ing a balloon support and the whole device would float in the stomach. The drug then would be released in a sustained and controlled fashion either due to the mechanical pressure exerted by a bladder on a closed drug reservoir, or dispensed from a container enclosed in a microporous membrane.
The spontaneous expulsion of such a device from the gastrointestinal tract once its active material has been expended is much more of a challenge, however. The Michaels device comes equipped with an imbedded bioerodible plug whose object is to assure the balloon's eventual deflation. In another version of the invention, the balloon loses air by being minimally permeable to a gas with which it has been inflated.
Place and Bashaw, et al disclose in U.S. Patents 3,797,492 and 3,944,064 a variation of the system described above, suggesting that a propellant-charged capsular compartment can keep the device afloat in the stomach and also accomplish the controlled release of the active drug. Another drug-dispensing device for the prolonged administration of pharmaceuticals is disclosed in U.S. Patent 4,207,890. This device is made of dual polymer envelopes, one of;which swells and expands
osmotically when the device reaches the stomach, while the other contains the drug and dispenses it at a pre¬ determined rate based on the polymer envelope's perme¬ ability characteristics. Yet, all these devices have major disadvantages in that they carry only a small amount of the active substance. Furthermore, as their balloon support becomes partially deflated in the stomach, this could result in their inadvertent passage into the duodenum and small intestine and produce a dangerous intestinal obstruction. Moreover, gas- or air-filled devices could burst if the individuals wearing them should travel to higher altitudes. Should the reverse occur, where an individual would travel to lower altitudes, the gas filled device could deflate.
Intragastric balloon devices have also been developed for the purpose of appetite control and weight reduction. Berman, et al (U.S. 4,133,315) describe a large balloon which is to be introduced deflated into the stomach via a naso-gastric tube. The balloon is to be fluid filled with an attached insufflation tube that remains in place and extends through the esophagus and the nasal passages to the outside environment. A more advanced concept of this intragastric balloon*weight loss device was disclosed in U.S. Patent 4,485,805. This elastomeric rubber balloon was equipped with a self- sealfng valve and its inflator tube could be withdrawn from the stomach, leaving behind the fluid inflated bal¬ loon. When the desired weight loss is achieved, the bal- loon is to be deflated, and withdrawn from the stomach by endoscopy. Although this device was primarily developed for weight control, the inventor suggests that pharmaceu¬ ticals could also be incorporated for sustained release into the fluid used for balloon inflation.
The Garren-Edwards gastric bubble consists of a self-sealing, cylindrical intragastric balloon which has been made commercially available for weight reduction and appetite control (Endoscopy Review, 1, 57-60, 1984). Recently, however, the phenomenon of bio or mucoadhesion with polymeric substances has received considerable attention ( "Advances in Drug Delivery Systems", J.M. Anderson and S.W. Kim, Eds., Elsevier, Amsterdam, Vol. 1, 1986, pp 47-57). The temporary and adhesive attachment of prolonged release drug delivery systems to the gastrointestinal mucosa is a novel ap¬ proach. However, the various mucoadhesive techniques are still under early experimental investigation.
There is clearly a need for a practical gastro-*- intestinal drug delivery device that is relatively simple, safe to use, and is able to release significant quantitie of active agent in a prolonged and controlled manner. Th objective of this invention is to provide a novel device that fulfills these requirements.
Disclosure of the Invention
The invention is an inflatable device which is introduced into the lumen of the stomach, and inflated while in the stomach in order to prevent it from progress ing into the lower gastrointestinal tract. A beneficial agent-containing cartridge is carried by the device and releases the"agent to the stomach or the intestinal tract. The device may include means by which it may be retrieved from the stomach. Accordingly, the invention is a removable inflatable intragastrointestinal beneficial agent deliver device adapted to reside within a stomach comprising:
(a) an inflatable member which is sized and shaped to pass through the esophagus in its deflated stat
and reside within the stomach and not pass through the pyloric sphincter in its inflated state;
(b) a hollow inflation tube for inflating the inflatable member one end of which is operably connected to the inflatable member and the other end of which car¬ ries a valve, said inflation tube having a length suf¬ ficient to extend from the mouth through the esophagus and into the stomach, providing a means by which the inflat¬ able member may be inflated from outside the body with an inflation medium, and being adapted to reside within the stomach after the inflatable member is inflated; and
(c) at least one cartridge member carried on the exterior of the inflatable member and/or the inflation tube, said member containing a beneficial agent and being capable of releasing said agent into the gastrointestinal tract.
The invention thus provides a removable platform from which drugs or other beneficial agents may be released into the gastrointestinal tract at predetermined doses and dosage regimens. The cartridge element(s) of the device is capable of receiving and holding, unit doses of the agent, thus facilitating tailoring the dose, and/or dosage regimen or the administration of a multiplicity of different agents simultaneously or in a predetermined sequence. Further, the cartridge may be designed so that the unit doses can be removed and/or replaced, thus making it possible £o alter or extend administration of the agent(s) at will.
Brief Description of the Drawings
In the drawings, which are not to scale and in which like parts are referred to by the same reference numeral:
-l-
Fig. 1 is a partly sectional view of an embodiment of the device in its inflated state residing within the stomach.
Fig. 2 is a partly sectional view of the device of Fig. 1 in its deflated state being placed within the stomach via a naso-gastric tube.
Fig. 3 is a partly sectional view of the device of Fig. 1 in its inflated state and a syringe for inflat¬ ing the device. Fig. 4 is a sectional view of a beneficial agent-containing cartridge unit of the device of Fig. 1 taken along line 4-4 of Fig. 3.
Fig. 5 is a sectional view of another embodiment of the invention device where the cartridges reside within a cavity in the inflatable member of the device.
Detailed Description of Embodiments Shown in Drawings
The term "beneficial agents" as used herein is intended to include drugs, vitamins, and other chemicals or compositions that are administered gastrointestinally to humans or animals to achieve a beneficial effect on the recipient. The term "drug" as used herein broadly includes physiologically and/or pharmacqlogically active substances for producing a local effect within the gastrointestinal tract or a systemic effect at a remote site within the body.
Figs. 1-4 depict an embodiment of the invention, generally designated 10. Device 10 is composed of three principal elements: an inflatable member 11, an inflation tube 12, and a plurality of beneficial agent-containing cartridges 13.
The inflatable member 11 is sized and shaped so that when deflated it can be inserted into the stomach 14 via a naso-gastric tube 15 (Fig. 2) that extends through the mouth 16 and esophagus 17 and opens into the stomach.
Its size and shape in the inflated state (Fig. 1) are suc that it resides comfortably within the stomach without being able to pass through the pyloric sphincter 18. While the inflated shape of member 11 is toroidal it will be appreciated that other shapes such as ovoidal, el¬ lipsoidal, spheroidal, triangular, and the like may be employed. Shapes that have a central opening (such as a toroidal shape) allow stomach contents to pass through th pyloric sphincter even if the device settles against the pyloric region of the stomach. For human use the volume of the inflated member will normally be 20 to 1,000 cc, preferably 50 to 500 cc. Member 11 may be made solely of an elastomeric polymer or be an elastomeric laminated composite of metal foil, polymer or fiber. Member 11 is inflated using hollow inflation tube 12, one end 18 (Fig. 3) of which operably connects into the lumen 19 of the inflatable member and the other end 20 of which carries a valve 21. The length of the tube is sufficient to extend through the mouth and esophagus and into the stomach with its end 20 outside the mouth. Valve 21 is designed to interconnect with a syringe 22 that may be charged with an inflation medium (either gas or liquid, preferably gas, and most preferably air) . Cartridges 13 are strung on inflation tube 12 in bead-like fashion. Referring to Fig. 4, each cartridge has a"n opening 23 through it that receives tube 12, thus enabling the cartridges to be so carried on the tube. It will be appreciated that the cartridges could interfit with, be carried by, or otherwise be affixed to the tube in other manners. As seen in Fig. 4 the cartridge may have a monolithic structure composed entirely of an agent (drug) formulation or agent dispersed in a matrix material. Alternatively, the cartridges may have a container structure composed of a housing or wall that
defines a lumen and an agent formulation within the lumen. In container-type cartridges the wall may be agent- permeable, semipermeable, porous, or bioerodible, depend¬ ing upon the nature of the agent release mechanism that is employed.
The structure and/or composition of the cartridge is preferably such that the release of agent from the cartridge will occur over a sustained period, e.g., from one day to one year. Various mechanisms to achieve sustained release such as diffusion, osmosis, bioerosion, swelling, dissolution or combinations thereof may be employed. Accordingly, in container-type cartridges the wall may have pores to permit gastric juice to enter the reservoir and contact the agent or agent- release mechanism within it. Alternatively, and dependin upon the nature of the agent release mechanism, the wall may be required to be permeable to the agent or be semipermeable to permit gastric fluid to be imbibed into the pocket to effect agent release by an osmotic mechanism.
The agent may be in the form of a solid, gel, microcapsule, or liquid, depending, again, upon the natur of the cartridge and may be neat or formulated with carri¬ ers or diluents. It may be present in the form of a multiplicity of individual dosage units to facilitate tailoring of the dose. Alternatively, a multiplicity of different agents may be contained in the cartridges to achieve multi-agent administration simultaneously or in a predetermined sequence or pattern. By using a multiplicity of unit dosage cartridges, doses may be easily adjusted via the number o cartridges. A cartridge may contain more than one agent or when more than one cartridge is employed the individua cartridges may contain different agents. The structure o the cartridge and/or the formulation of the agent within
the cartridge are preferably such that the release of agent from the cartridge will be over a sustained time period.
Fig. 2 shows the manner in which device 10 is inserted into the stomach. The naso-gastric tube 15 is first inserted through the mouth and esophagus into the stomach. The device in its deflated state is then plunged down the tube 15 and into the stomach using a plunger 24. At this time, the valve end of the trailing inflation tube is left outside of the oral cavity. After the inflatable member has reached the stomach it is inflated with the desired inflation medium using a syringe or other infla¬ tion device. Once inflated, the size/shape of the inflat¬ able member prevents the device from passing through the pyloric sphincter and entering the lower gastrointestinal tract. Finally, the inflation tube and valve are allowed to pass into the stomach. Then a fiberoptic gastroscope would be employed to ascertain the inflation and the gastric position of the device. Alternatively, the materials used to make the device may include a component that renders one or more elements of the device opaque to radiation, thereby permitting the device to be "seen" by conventional medical imaging devices.
The device may be left in the stomach from one day to one year for the sustained release of the agent from the cartridges.
The endoscopist may choose to add and/or remove beneficial agent cartridges once the device has been placed in the stomach. This could be achieved by retriev- ing the valve end of the tube magnetically using a magnetic ring 25 affixed to the valve end of the tube. After the endoscopist locates the valve, it would be magnetically retracted from the stomach, through the esophagus, with the trailing string of beneficial agent
- J 0- bearing cartridges. The addition or removal of cartridges could thus be performed.
Alternatively, the endoscopist may choose to leave the entire inflator valve and its trailing tubing in the stomach for the duration of the therapy, or use a heated endoscopic probe to heat-seal the tube at several points past the drug-bearing cartridges. Then the proximal section of the tube with its attached valve 21 could be cut and removed from the stomach by endoscopic forceps. hen the beneficial agent content of the device has been exhausted and/or if an early or temporary inter¬ ruption of the administration is desired, the inflatable member could be either deflated or punctured endoscopically and recovered from the stomach by pulling it through the esophagus into the mouth with endoscopic forceps. An alternative recovery procedure would retrieve the valve end of the inflation tube magnetically and deflate the inflatable member with a syringe, thereby af- fording a smooth withdrawal of the entire device from the gastric lumen.
Fig. 5 depicts another embodiment of the inven¬ tion device, generally designated 26. Device 26 differs from device 10 as regards the structure of the inflatable member and the manner in which the agent-containing cartridges are carried. Device 26 has an inflatable memb r 27 thit is generally ellipsoidal in shape in its inflated state (shown in Fig. 5) and has an opening or channel 28 extending through it. Opening 28 defines a cavity in which cartridges 13 reside. The ends of the opening are closed by caps 29 which have perforations 30 to permit gastric fluids to flow into and through the opening, thereby contacting cartridges 13. In its deflated state (not shown) the profile of device 26 is essentially that of the cartridge-containing channel.
- l l -
Devices of such structure have the feature that the agent* containing capsules are kept from contacting the gastric mucosa directly. It should be noted that the cartridges are considered to be carried on the "exterior" of the inflatable member even though they are confined within channel 28. In this regard the term "exterior" intends any surface of the inflatable member that is capable of direct contact with gastric fluids when the device is in the stomach. Other embodiments of the invention that are obvious to those of skill in the fields of drug delivery devices, endoscopy, or related fields are intended to be within the scope of the following claims.
Claims
1. A removable inflatable intragastrointestinal beneficial agent delivery device adapted to reside within a stomach comprising:
(a) an inflatable member which is sized and shaped to pass through the esophagus in its deflated state and reside within the stomach and not pass through the pyloric sphincter in its inflated state;
(b) a hollow inflation tube for inflating the inflatable member once the inflatable member is within the stomach, one end of which is operably connected to the inflatable member and the other end of which carries a valve, said inflation tube having a length sufficient to extend from the mouth through the esophagus and into the stomach, providing a means by which the inflatable member may be inflated from outside the body and being adapted to reside within the stomach after the inflatable member is inflated;
(c) at least one cartridge member carried on the exterior of the inflatable member and/or the inflation tube, said member containing a beneficial agent and being capable of releasing said agent into the gastrointestinal tract.
2 . - The device of claim 1 wherein the beneficial agent is a drug.
3. The device of claim 1 including:
(d) a magnetic body carried proximate to said other end of the inflation tube and providing a means by which the inflation tube may be magnetically retrieved from the stomach via the esophagus and mouth. - 13-
4. The device of claim 1 wherein the cartridge is carried on the inflation tube, has an opening through it and is strung on the inflation tube via the opening.
5. The device of claim 4 wherein there is a plurality of cartridges, each of which has an opening through it, said cartridges being strung on the inflation tube via the openings.
6. The device of claim 1 wherein the cartridge is carried on the exterior of the inflatable member, and the inflatable member has an opening through it that provides a cavity in which the cartridge resides.
7. The device of claim 6 wherein the ends of the opening are closed by perforated members.
8. The device of claim 6 wherein there is a plurality of cartridges each of which resides in the cav- ity.
9. The device of claim 1 wherein the inflatabl member has a toroidal shape in its inflated state.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/215,746 US4925446A (en) | 1988-07-06 | 1988-07-06 | Removable inflatable intragastrointestinal device for delivering beneficial agents |
US215,746 | 1988-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1990000369A1 true WO1990000369A1 (en) | 1990-01-25 |
Family
ID=22804217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/002924 WO1990000369A1 (en) | 1988-07-06 | 1989-07-05 | A removable inflatable intragastrointestinal device for delivering beneficial agents |
Country Status (3)
Country | Link |
---|---|
US (1) | US4925446A (en) |
AU (1) | AU3873489A (en) |
WO (1) | WO1990000369A1 (en) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1732635A2 (en) * | 2004-03-18 | 2006-12-20 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
WO2007027812A2 (en) | 2005-08-29 | 2007-03-08 | Baronova, Inc. | Gastric retaining devices and methods |
WO2007076021A2 (en) * | 2005-12-22 | 2007-07-05 | Wilson-Cook Medical Inc. | Intragastric bag for treating obesity |
WO2007075978A3 (en) * | 2005-12-22 | 2007-11-29 | Wilson Cook Medical Inc | Coiled intragastric member for treating obesity |
FR2906132A1 (en) * | 2006-09-25 | 2008-03-28 | Cie Euro Etude Rech Paroscopie | INTRA-GASTRIC BALLOON WITH CATHETER BRAND. |
EP1979039A2 (en) * | 2006-02-03 | 2008-10-15 | Baronova, Inc. | Gastro-intestinal device and method for treating addiction |
EP2142243A1 (en) * | 2007-03-30 | 2010-01-13 | Reshape Medical | Intragastric balloon system and therapeutic processes and products |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
US8845513B2 (en) | 2002-08-13 | 2014-09-30 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding device |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
US8888797B2 (en) | 2007-09-07 | 2014-11-18 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
US8900118B2 (en) | 2008-10-22 | 2014-12-02 | Apollo Endosurgery, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
US8900117B2 (en) | 2004-01-23 | 2014-12-02 | Apollo Endosurgery, Inc. | Releasably-securable one-piece adjustable gastric band |
US8905915B2 (en) | 2006-01-04 | 2014-12-09 | Apollo Endosurgery, Inc. | Self-regulating gastric band with pressure data processing |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US9050165B2 (en) | 2010-09-07 | 2015-06-09 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding system |
US9149611B2 (en) | 2010-02-08 | 2015-10-06 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9174031B2 (en) | 2009-03-13 | 2015-11-03 | Reshape Medical, Inc. | Device and method for deflation and removal of implantable and inflatable devices |
US9192501B2 (en) | 2010-04-30 | 2015-11-24 | Apollo Endosurgery, Inc. | Remotely powered remotely adjustable gastric band system |
US9283102B2 (en) | 2007-06-25 | 2016-03-15 | Reshape Medical, Inc. | Gastric space filler device, delivery system, and related methods |
US9295573B2 (en) | 2010-04-29 | 2016-03-29 | Apollo Endosurgery, Inc. | Self-adjusting gastric band having various compliant components and/or a satiety booster |
US9358143B2 (en) | 2009-07-22 | 2016-06-07 | Reshape Medical, Inc. | Retrieval mechanisms for implantable medical devices |
US9498366B2 (en) | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
US9604038B2 (en) | 2009-07-23 | 2017-03-28 | Reshape Medical, Inc. | Inflation and deflation mechanisms for inflatable medical devices |
US9622896B2 (en) | 2010-02-08 | 2017-04-18 | Reshape Medical, Inc. | Enhanced aspiration processes and mechanisms for instragastric devices |
US9629740B2 (en) | 2010-04-06 | 2017-04-25 | Reshape Medical, Inc. | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9668900B2 (en) | 2002-05-09 | 2017-06-06 | Reshape Medical, Inc. | Balloon system and methods for treating obesity |
US9681973B2 (en) | 2010-02-25 | 2017-06-20 | Reshape Medical, Inc. | Enhanced explant processes and mechanisms for intragastric devices |
US9700450B2 (en) | 2003-07-28 | 2017-07-11 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US9962276B2 (en) | 2005-10-31 | 2018-05-08 | Reshape Medical Llc | Intragastric space filler |
US9987470B2 (en) | 2009-07-23 | 2018-06-05 | ReShape Medical, LLC | Deflation and removal of implantable medical devices |
US10070981B2 (en) | 2013-03-15 | 2018-09-11 | Baronova, Inc. | Locking gastric obstruction device and method of use |
Families Citing this family (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000376A1 (en) * | 1988-07-05 | 1990-01-25 | Cantenys Jose | Intragastric balloon |
US5198229A (en) * | 1991-06-05 | 1993-03-30 | Alza Corporation | Self-retaining gastrointestinal delivery device |
US5318530A (en) * | 1991-12-06 | 1994-06-07 | Bissel Medical Products, Inc. | Gastrointestinal tube with inflatable bolus |
US5374243A (en) * | 1993-07-06 | 1994-12-20 | Alpha Therapeutic Corporation | Oxygen permeable bag containing oxygen-transporting perfluorochemical for providing oxygen internally to mammals |
US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
US6206930B1 (en) * | 1998-08-10 | 2001-03-27 | Charlotte-Mecklenburg Hospital Authority | Absorbable tissue expander |
US6293923B1 (en) | 1999-03-15 | 2001-09-25 | Innoventions, Inc. | Intravesicular balloon |
AU4483100A (en) | 1999-04-23 | 2000-11-10 | Situs Corporation | Pressure responsive valve for use with an intravesical infuser |
US6139535A (en) * | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
WO2001030420A1 (en) | 1999-10-28 | 2001-05-03 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
US7374532B2 (en) * | 2000-04-14 | 2008-05-20 | Attenuex Technologies, Inc. | High vapor pressure attenuation device |
US10327880B2 (en) | 2000-04-14 | 2019-06-25 | Attenuex Technologies, Inc. | Attenuation device for use in an anatomical structure |
US6682473B1 (en) | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
US7470228B2 (en) * | 2000-04-14 | 2008-12-30 | Attenuex Technologies, Inc. | Method of treating benign hypertrophy of the prostate |
US7033373B2 (en) | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
US6579301B1 (en) * | 2000-11-17 | 2003-06-17 | Syntheon, Llc | Intragastric balloon device adapted to be repeatedly varied in volume without external assistance |
US7643887B2 (en) * | 2001-05-01 | 2010-01-05 | Intrapace, Inc. | Abdominally implanted stimulator and method |
US7689284B2 (en) * | 2001-05-01 | 2010-03-30 | Intrapace, Inc. | Pseudounipolar lead for stimulating a digestive organ |
US7020531B1 (en) | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US7702394B2 (en) | 2001-05-01 | 2010-04-20 | Intrapace, Inc. | Responsive gastric stimulator |
US7616996B2 (en) * | 2005-09-01 | 2009-11-10 | Intrapace, Inc. | Randomized stimulation of a gastrointestinal organ |
US20080065169A1 (en) * | 2001-05-01 | 2008-03-13 | Intrapace, Inc. | Endoscopic Instrument for Engaging a Device |
US7747322B2 (en) * | 2001-05-01 | 2010-06-29 | Intrapace, Inc. | Digestive organ retention device |
US7979127B2 (en) * | 2001-05-01 | 2011-07-12 | Intrapace, Inc. | Digestive organ retention device |
US7756582B2 (en) * | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
US20050143784A1 (en) | 2001-05-01 | 2005-06-30 | Imran Mir A. | Gastrointestinal anchor with optimal surface area |
US9668690B1 (en) | 2001-05-01 | 2017-06-06 | Intrapace, Inc. | Submucosal gastric implant device and method |
ATE410123T1 (en) * | 2001-05-17 | 2008-10-15 | Wilson Cook Medical Inc | INTRAGASTRAL DEVICE FOR TREATING OBESITY |
US7083629B2 (en) | 2001-05-30 | 2006-08-01 | Satiety, Inc. | Overtube apparatus for insertion into a body |
US6558400B2 (en) | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
FR2827502B1 (en) * | 2001-07-17 | 2004-04-09 | Univ Joseph Fourier | MICROMUSCLE IN A BIOLOGICAL ENVIRONMENT |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7097665B2 (en) | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
CN101810521B (en) | 2001-08-27 | 2015-05-13 | 辛尼科有限责任公司 | Satiation devices and methods |
US6845776B2 (en) * | 2001-08-27 | 2005-01-25 | Richard S. Stack | Satiation devices and methods |
WO2003075256A1 (en) * | 2002-03-05 | 2003-09-12 | Nec Corporation | Image display and its control method |
US7146984B2 (en) * | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
US6746460B2 (en) | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
EP2181655B1 (en) | 2002-08-28 | 2016-12-07 | Apollo Endosurgery, Inc. | Fatigue-restistant gastric banding device |
US7214233B2 (en) | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US6981978B2 (en) * | 2002-08-30 | 2006-01-03 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US7220237B2 (en) | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7229428B2 (en) * | 2002-10-23 | 2007-06-12 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
IL152630A (en) * | 2002-11-04 | 2010-11-30 | Innoventions Ltd | Implantable device |
US6656194B1 (en) | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
US20040143221A1 (en) * | 2002-12-27 | 2004-07-22 | Shadduck John H. | Biomedical implant for sustained agent release |
US20040143342A1 (en) * | 2003-01-16 | 2004-07-22 | Stack Richard S. | Satiation pouches and methods of use |
US20060058829A1 (en) * | 2003-03-19 | 2006-03-16 | Sampson Douglas C | Intragastric volume-occupying device |
US6981980B2 (en) * | 2003-03-19 | 2006-01-03 | Phagia Technology | Self-inflating intragastric volume-occupying device |
US7175638B2 (en) | 2003-04-16 | 2007-02-13 | Satiety, Inc. | Method and devices for modifying the function of a body organ |
US7611480B2 (en) * | 2003-04-24 | 2009-11-03 | Levy Mark M | Gastrointestinal bioreactor |
US8821521B2 (en) * | 2003-07-28 | 2014-09-02 | Baronova, Inc. | Gastro-intestinal device and method for treating addiction |
US8048169B2 (en) * | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
US8206456B2 (en) | 2003-10-10 | 2012-06-26 | Barosense, Inc. | Restrictive and/or obstructive implant system for inducing weight loss |
US20050247320A1 (en) * | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US7914543B2 (en) | 2003-10-14 | 2011-03-29 | Satiety, Inc. | Single fold device for tissue fixation |
US7097650B2 (en) | 2003-10-14 | 2006-08-29 | Satiety, Inc. | System for tissue approximation and fixation |
US20050177176A1 (en) | 2004-02-05 | 2005-08-11 | Craig Gerbi | Single-fold system for tissue approximation and fixation |
US8828025B2 (en) | 2004-02-13 | 2014-09-09 | Ethicon Endo-Surgery, Inc. | Methods and devices for reducing hollow organ volume |
US7708684B2 (en) | 2004-02-27 | 2010-05-04 | Satiety, Inc. | Methods and devices for reducing hollow organ volume |
EP1725193B1 (en) | 2004-03-08 | 2009-09-30 | Allergan Medical S.A. | Closure system for tubular organs |
US9028511B2 (en) | 2004-03-09 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8449560B2 (en) | 2004-03-09 | 2013-05-28 | Satiety, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8252009B2 (en) | 2004-03-09 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8628547B2 (en) | 2004-03-09 | 2014-01-14 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
AU2005231323B2 (en) | 2004-03-26 | 2011-03-31 | Ethicon Endo-Surgery, Inc | Systems and methods for treating obesity |
US7717843B2 (en) * | 2004-04-26 | 2010-05-18 | Barosense, Inc. | Restrictive and/or obstructive implant for inducing weight loss |
US20060070334A1 (en) * | 2004-09-27 | 2006-04-06 | Blue Hen, Llc | Sidewall plank for constructing a trailer and associated trailer sidewall construction |
US20070078476A1 (en) * | 2004-10-12 | 2007-04-05 | Hull Wendell C Sr | Overweight control apparatuses for insertion into the stomach |
US20060106288A1 (en) | 2004-11-17 | 2006-05-18 | Roth Alex T | Remote tissue retraction device |
US8070807B2 (en) | 2004-11-19 | 2011-12-06 | Fulfillium, Inc. | Wireless breach detection |
US9456915B2 (en) | 2004-11-19 | 2016-10-04 | Fulfilium, Inc. | Methods, devices, and systems for obesity treatment |
US9974680B2 (en) | 2004-12-27 | 2018-05-22 | Spatz Fgia, Inc. | System and methods for internalization of external components of adjustable intragastric balloon |
US8403952B2 (en) * | 2004-12-27 | 2013-03-26 | Spatz-Fgia, Inc. | Floating gastrointestinal anchor |
US20060142731A1 (en) * | 2004-12-27 | 2006-06-29 | Jeffrey Brooks | Floating gastro-intestinal anchor |
WO2014082044A1 (en) | 2012-11-26 | 2014-05-30 | Spatz Fgia, Inc. | System and methods for internalization of components of an adjustable intragastric balloon |
WO2006078672A1 (en) * | 2005-01-19 | 2006-07-27 | Baker Randal S | Medical agent delivery system and method |
US7699818B2 (en) * | 2005-02-08 | 2010-04-20 | Paul J. Gilbert | Insertion system and methods for nasogastric tubes |
US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
JP4996598B2 (en) * | 2005-05-09 | 2012-08-08 | クック メディカル テクノロジーズ エルエルシー | Intragastric device for the treatment of obesity |
JP2008545508A (en) | 2005-06-10 | 2008-12-18 | ウィルソン−クック・メディカル・インコーポレーテッド | Ablation catheter |
US8216266B2 (en) * | 2005-06-16 | 2012-07-10 | Hively Robert L | Gastric bariatric apparatus with selective inflation and safety features |
WO2007038476A2 (en) | 2005-09-26 | 2007-04-05 | Atteneux Technologies, Inc. | Pressure attenuation device |
US9055942B2 (en) | 2005-10-03 | 2015-06-16 | Boston Scienctific Scimed, Inc. | Endoscopic plication devices and methods |
US7509175B2 (en) | 2006-08-03 | 2009-03-24 | Intrapace, Inc. | Method and devices for stimulation of an organ with the use of a transectionally placed guide wire |
US20090018606A1 (en) * | 2005-10-12 | 2009-01-15 | Intrapace, Inc. | Methods and Devices for Stimulation of an Organ with the Use of a Transectionally Placed Guide Wire |
US20070207199A1 (en) * | 2005-12-28 | 2007-09-06 | Sogin Stephen J | Appetite suppression device |
US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
US8430894B2 (en) * | 2006-03-28 | 2013-04-30 | Spatz-Fgia, Inc. | Floating gastrointestinal anchor |
US20080215075A1 (en) * | 2006-09-01 | 2008-09-04 | Albrecht Thomas E | Implantable coil for insertion into a hollow body organ |
US20080097510A1 (en) * | 2006-09-01 | 2008-04-24 | Albrecht Thomas E | Method for inducing weight loss with a patient |
US20080058840A1 (en) * | 2006-09-01 | 2008-03-06 | Albrecht Thomas E | Implantable coil for insertion into a hollow body organ |
US10350099B2 (en) | 2006-09-01 | 2019-07-16 | Ethicon Endo-Surgery, Inc. | Devices and methods for anchoring an endoluminal sleeve in the GI tract |
US20080161935A1 (en) * | 2006-09-01 | 2008-07-03 | Albrecht Thomas E | Method for inducting weight loss using a coil for insertion into a hollow body organ |
US8109895B2 (en) | 2006-09-02 | 2012-02-07 | Barosense, Inc. | Intestinal sleeves and associated deployment systems and methods |
EP2068719B1 (en) * | 2006-09-15 | 2017-10-25 | Boston Scientific Scimed, Inc. | System for anchoring stomach implant |
US20080086082A1 (en) * | 2006-10-06 | 2008-04-10 | Brooks Jeffrey S | Radiopaque marking to detect balloon deflation |
EP2134303A1 (en) * | 2007-03-29 | 2009-12-23 | Jaime Vargas | Intragastric implant devices |
WO2008132745A2 (en) * | 2007-04-30 | 2008-11-06 | Spatz Fgia, Inc. | Non-endoscopic insertion and removal of a device |
US8007507B2 (en) * | 2007-05-10 | 2011-08-30 | Cook Medical Technologies Llc | Intragastric bag apparatus and method of delivery for treating obesity |
US20080306506A1 (en) * | 2007-06-11 | 2008-12-11 | Leatherman Dennis A | Self-inflating and deflating intragastric balloon implant device |
US20100082046A1 (en) * | 2007-07-18 | 2010-04-01 | Harris Jason L | Device For Deploying A Fastener For Use in a Gastric Volume Reduction Procedure |
AU2008276523B2 (en) | 2007-07-18 | 2014-08-21 | Boston Scientific Scimed, Inc. | Endoscopic implant system and method |
WO2009011881A1 (en) | 2007-07-18 | 2009-01-22 | Barosense, Inc. | Overtube introducer for use in endoscopic bariatric surgery |
US8066715B2 (en) * | 2007-10-03 | 2011-11-29 | Cook Medical Technologies Llc | Magnetic stent removal |
US8303573B2 (en) * | 2007-10-17 | 2012-11-06 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8707964B2 (en) * | 2007-10-31 | 2014-04-29 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US20090105561A1 (en) * | 2007-10-17 | 2009-04-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Medical or veterinary digestive tract utilization systems and methods |
US8789536B2 (en) * | 2007-10-17 | 2014-07-29 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8038659B2 (en) * | 2007-10-17 | 2011-10-18 | The Invention Science Fund I, Llc | Disintegrating digestive tract interaction system |
US8808276B2 (en) * | 2007-10-23 | 2014-08-19 | The Invention Science Fund I, Llc | Adaptive dispensation in a digestive tract |
US20090163894A1 (en) * | 2007-10-31 | 2009-06-25 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Medical or veterinary digestive tract utilization systems and methods |
US8109920B2 (en) * | 2007-10-31 | 2012-02-07 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8333754B2 (en) * | 2007-10-31 | 2012-12-18 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US8808271B2 (en) * | 2007-10-31 | 2014-08-19 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US20090137866A1 (en) * | 2007-11-28 | 2009-05-28 | Searete Llc, A Limited Liability Corporation Of The State Delaware | Medical or veterinary digestive tract utilization systems and methods |
US20090149879A1 (en) * | 2007-12-10 | 2009-06-11 | Dillon Travis E | Dynamic volume displacement weight loss device |
US7883524B2 (en) * | 2007-12-21 | 2011-02-08 | Wilson-Cook Medical Inc. | Method of delivering an intragastric device for treating obesity |
US8016851B2 (en) * | 2007-12-27 | 2011-09-13 | Cook Medical Technologies Llc | Delivery system and method of delivery for treating obesity |
US20090171383A1 (en) | 2007-12-31 | 2009-07-02 | David Cole | Gastric space occupier systems and methods of use |
US8020741B2 (en) | 2008-03-18 | 2011-09-20 | Barosense, Inc. | Endoscopic stapling devices and methods |
US8092479B2 (en) * | 2008-06-27 | 2012-01-10 | Ethicon Endo-Surgery, Inc. | Implantable device for the treatment of obesity |
US8236022B2 (en) * | 2008-06-27 | 2012-08-07 | Ethicon Endo-Surgery, Inc. | Implantable device for the treatment of obesity |
US20100087706A1 (en) * | 2008-09-30 | 2010-04-08 | Intrapace, Inc. | Lead Access |
EP2362762A1 (en) | 2008-10-06 | 2011-09-07 | Allergan Medical Sàrl | Mechanical gastric band with cushions |
WO2010045477A2 (en) | 2008-10-16 | 2010-04-22 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
US7934631B2 (en) | 2008-11-10 | 2011-05-03 | Barosense, Inc. | Multi-fire stapling systems and methods for delivering arrays of staples |
EP2367503A1 (en) | 2008-11-25 | 2011-09-28 | AttenueX Technologies, Inc. | Implant with high vapor pressure medium |
WO2010093951A1 (en) * | 2009-02-13 | 2010-08-19 | Intrapace, Inc. | Endoscopic forceps with removable handle |
US8100932B2 (en) | 2009-03-31 | 2012-01-24 | Onciomed, Inc. | Method and apparatus for treating obesity and controlling weight gain using self-expanding intragastric devices |
EP2414032A4 (en) * | 2009-04-03 | 2016-08-10 | Intrapace Inc | Feedback systems and methods for communicating diagnostic and/or treatment signals to enhance obesity treatments |
US8961539B2 (en) * | 2009-05-04 | 2015-02-24 | Boston Scientific Scimed, Inc. | Endoscopic implant system and method |
US20110092998A1 (en) * | 2009-10-13 | 2011-04-21 | Spatz Fgia, Inc. | Balloon hydraulic and gaseous expansion system |
US9532892B2 (en) | 2009-10-21 | 2017-01-03 | Apollo Endosurgery, Inc. | Bariatric device and method for weight loss |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
ES2536055T3 (en) | 2010-03-15 | 2015-05-20 | Apollo Endosurgery, Inc. | Bariatric device and weight loss method |
WO2011120047A1 (en) | 2010-03-26 | 2011-09-29 | IBIS Medical, Inc. | Intragastric implant devices |
CA2799774A1 (en) | 2010-05-21 | 2011-11-24 | Barosense, Inc. | Tissue-acquisition and fastening devices and methods |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
WO2012045030A2 (en) | 2010-10-01 | 2012-04-05 | Intrapace, Inc. | Feedback systems and methods to enhance obstructive and other obesity treatments, optionally using multiple sensors |
EP2627291A2 (en) * | 2010-10-11 | 2013-08-21 | Allergan, Inc. | Re-shaping intragastric implants |
EP2629714B1 (en) | 2010-10-18 | 2015-12-30 | Apollo Endosurgery, Inc. | Intragastric implants with duodenal anchors |
ES2565348T3 (en) | 2010-10-18 | 2016-04-04 | Apollo Endosurgery, Inc. | Intragastric implant reagent devices |
US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
US9463107B2 (en) | 2010-10-18 | 2016-10-11 | Apollo Endosurgery, Inc. | Variable size intragastric implant devices |
US9233016B2 (en) | 2010-10-18 | 2016-01-12 | Apollo Endosurgery, Inc. | Elevating stomach stimulation device |
US9498365B2 (en) | 2010-10-19 | 2016-11-22 | Apollo Endosurgery, Inc. | Intragastric implants with multiple fluid chambers |
US8920447B2 (en) | 2010-10-19 | 2014-12-30 | Apollo Endosurgery, Inc. | Articulated gastric implant clip |
US9198790B2 (en) | 2010-10-19 | 2015-12-01 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US9398969B2 (en) | 2010-10-19 | 2016-07-26 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US20120095483A1 (en) | 2010-10-19 | 2012-04-19 | Allergan, Inc. | Anchored non-piercing duodenal sleeve and delivery systems |
US9095405B2 (en) | 2010-10-19 | 2015-08-04 | Apollo Endosurgery, Inc. | Space-filling intragastric implants with fluid flow |
US8864840B2 (en) | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
ES2356655B1 (en) * | 2010-12-29 | 2011-11-22 | Ramon Abad Belando | GASTRIC INTRODUCTION DEVICE. |
NO3117865T3 (en) | 2011-01-21 | 2018-04-07 | ||
US8292911B2 (en) | 2011-01-21 | 2012-10-23 | Obalon Therapeutics, Inc. | Intragastric device |
US8202291B1 (en) | 2011-01-21 | 2012-06-19 | Obalon Therapeutics, Inc. | Intragastric device |
US8647358B2 (en) | 2011-01-21 | 2014-02-11 | Obalon Therapeutics Inc. | Intragastric device |
WO2013025993A1 (en) | 2011-08-18 | 2013-02-21 | Gilbert Paul J | Fluid characteristic measurement |
CN103974741A (en) | 2011-09-27 | 2014-08-06 | Ibis医药股份有限公司 | Intragastric implant devices |
FR2983399B1 (en) * | 2011-12-01 | 2014-12-05 | Life Partners Europ | INTRA-GASTRIC DEVICE WITH VARIABLE VOLUME |
US9750660B2 (en) * | 2012-03-30 | 2017-09-05 | Ethicon Endo-Surgery, Inc. | Devices and methods for the treatment of metabolic disorders |
CN104334123B (en) | 2012-06-07 | 2019-02-12 | 意比图密医疗有限公司 | Expansion device |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
US8894563B2 (en) | 2012-08-10 | 2014-11-25 | Attenuex Technologies, Inc. | Methods and systems for performing a medical procedure |
WO2014040064A1 (en) * | 2012-09-10 | 2014-03-13 | Boston Scientific Scimed, Inc. | Catheter with releasable balloon and related methods |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
US9456917B2 (en) | 2013-08-28 | 2016-10-04 | Ethicon Endo-Surgery, Inc. | Endoscopic transoral duodenal sleeve applier |
BR112016012548B1 (en) | 2013-12-04 | 2022-04-05 | Obalon Therapeutics, Inc | ELECTROMAGNETIC SYSTEM TO LOCATE INFLATABLE INTRAGASTRIC DEVICE INSIDE THE BODY |
CN105899198A (en) | 2013-12-05 | 2016-08-24 | 图利普医疗有限公司 | Retentive devices and systems for in-situ release of pharmaceutical active agents |
US9895248B2 (en) | 2014-10-09 | 2018-02-20 | Obalon Therapeutics, Inc. | Ultrasonic systems and methods for locating and/or characterizing intragastric devices |
US10335303B2 (en) | 2015-12-07 | 2019-07-02 | Obalon Therapeutics, Inc. | Intragastric device |
US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
US10350100B2 (en) | 2016-04-12 | 2019-07-16 | Obalon Therapeutics, Inc. | System for detecting an intragastric balloon |
WO2018085079A1 (en) | 2016-11-04 | 2018-05-11 | Obalon Therapeutics, Inc. | Pressure control system for intragastric device |
CN110461408B (en) * | 2017-02-09 | 2022-01-21 | 斯帕茨菲亚有限公司 | Check valve with docking station for gastrointestinal balloon |
WO2019232292A1 (en) * | 2018-05-31 | 2019-12-05 | Massachusetts Institute Of Technology | Resident articles for gram-level dosing |
US20200254226A1 (en) | 2019-02-07 | 2020-08-13 | Solace Therapeutics, Inc. | Pressure attenuation device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3589356A (en) * | 1969-09-04 | 1971-06-29 | Daniel Silverman | Method for everting and extraverting flexible tubing into a body cavity |
US3901232A (en) * | 1973-10-26 | 1975-08-26 | Alza Corp | Integrated device for administering beneficial drug at programmed rate |
US4416267A (en) * | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4055178A (en) * | 1976-03-10 | 1977-10-25 | Harrigan Roy Major | Drug delivery device for preventing contact of undissolved drug with the stomach lining |
US4133315A (en) * | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
US4207890A (en) * | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
WO1980000007A1 (en) * | 1978-06-02 | 1980-01-10 | A Rockey | Medical sleeve |
US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
FR2582222A1 (en) * | 1985-05-21 | 1986-11-28 | Applied Precision Ltd | IMPLANTABLE MANUAL ACTION DEVICE FOR THE SEQUENTIAL DELIVERY OF DOSES OF A SUBSTANCE, ESPECIALLY THERAPEUTIC |
-
1988
- 1988-07-06 US US07/215,746 patent/US4925446A/en not_active Expired - Fee Related
-
1989
- 1989-07-05 AU AU38734/89A patent/AU3873489A/en not_active Abandoned
- 1989-07-05 WO PCT/US1989/002924 patent/WO1990000369A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3589356A (en) * | 1969-09-04 | 1971-06-29 | Daniel Silverman | Method for everting and extraverting flexible tubing into a body cavity |
US3901232A (en) * | 1973-10-26 | 1975-08-26 | Alza Corp | Integrated device for administering beneficial drug at programmed rate |
US4416267A (en) * | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
Cited By (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9668900B2 (en) | 2002-05-09 | 2017-06-06 | Reshape Medical, Inc. | Balloon system and methods for treating obesity |
US8845513B2 (en) | 2002-08-13 | 2014-09-30 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding device |
US11197774B2 (en) | 2003-07-28 | 2021-12-14 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US9687243B2 (en) | 2003-07-28 | 2017-06-27 | Baronova, Inc. | Gastric retaining devices and methods |
US9498366B2 (en) | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
US9510834B2 (en) | 2003-07-28 | 2016-12-06 | Baronova, Inc. | Gastric retaining devices and methods |
US9931122B2 (en) | 2003-07-28 | 2018-04-03 | Baronova, Inc. | Gastric retaining devices and methods |
US9924948B2 (en) | 2003-07-28 | 2018-03-27 | Baronova, Inc. | Gastric retaining devices and methods |
US9642735B2 (en) | 2003-07-28 | 2017-05-09 | Baronova, Inc. | Pyloric valve corking device |
US9700450B2 (en) | 2003-07-28 | 2017-07-11 | Baronova, Inc. | Devices and methods for gastrointestinal stimulation |
US8900117B2 (en) | 2004-01-23 | 2014-12-02 | Apollo Endosurgery, Inc. | Releasably-securable one-piece adjustable gastric band |
AU2004317849B2 (en) * | 2004-03-18 | 2011-03-31 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
EP1732635A2 (en) * | 2004-03-18 | 2006-12-20 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
EP1732635A4 (en) * | 2004-03-18 | 2009-05-27 | Allergan Inc | Apparatus and method for volume adjustment of intragastric balloons |
WO2007027812A2 (en) | 2005-08-29 | 2007-03-08 | Baronova, Inc. | Gastric retaining devices and methods |
EP1919370A4 (en) * | 2005-08-29 | 2015-07-29 | Baronova Inc | Gastric retaining devices and methods |
US9962276B2 (en) | 2005-10-31 | 2018-05-08 | Reshape Medical Llc | Intragastric space filler |
AU2006330911B2 (en) * | 2005-12-22 | 2012-10-04 | Cook Medical Technologies Llc | Intragastric bag for treating obesity |
WO2007076021A3 (en) * | 2005-12-22 | 2007-11-22 | Wilson Cook Medical Inc | Intragastric bag for treating obesity |
WO2007076021A2 (en) * | 2005-12-22 | 2007-07-05 | Wilson-Cook Medical Inc. | Intragastric bag for treating obesity |
WO2007075978A3 (en) * | 2005-12-22 | 2007-11-29 | Wilson Cook Medical Inc | Coiled intragastric member for treating obesity |
US8905915B2 (en) | 2006-01-04 | 2014-12-09 | Apollo Endosurgery, Inc. | Self-regulating gastric band with pressure data processing |
EP1979039A4 (en) * | 2006-02-03 | 2013-10-30 | Baronova Inc | Gastro-intestinal device and method for treating addiction |
EP1979039A2 (en) * | 2006-02-03 | 2008-10-15 | Baronova, Inc. | Gastro-intestinal device and method for treating addiction |
FR2906132A1 (en) * | 2006-09-25 | 2008-03-28 | Cie Euro Etude Rech Paroscopie | INTRA-GASTRIC BALLOON WITH CATHETER BRAND. |
WO2008037890A2 (en) * | 2006-09-25 | 2008-04-03 | Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie | Intragastric balloon with marked catheter |
WO2008037890A3 (en) * | 2006-09-25 | 2008-06-05 | Cie Euro Etude Rech Paroscopie | Intragastric balloon with marked catheter |
EP2142243A4 (en) * | 2007-03-30 | 2014-11-19 | Reshape Medical | Intragastric balloon system and therapeutic processes and products |
EP2142243A1 (en) * | 2007-03-30 | 2010-01-13 | Reshape Medical | Intragastric balloon system and therapeutic processes and products |
US9283102B2 (en) | 2007-06-25 | 2016-03-15 | Reshape Medical, Inc. | Gastric space filler device, delivery system, and related methods |
US8888797B2 (en) | 2007-09-07 | 2014-11-18 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
US10736763B2 (en) | 2007-09-07 | 2020-08-11 | Baronova, Inc. | Device for intermittently obstructing a gastric opening |
US10166133B2 (en) | 2007-09-07 | 2019-01-01 | Baronova, Inc. | Device for intermittently obstructing a gastric opening |
US9504591B2 (en) | 2007-09-07 | 2016-11-29 | Baronova, Inc. | Device for intermittently obstructing a gastric opening and method of use |
US8900118B2 (en) | 2008-10-22 | 2014-12-02 | Apollo Endosurgery, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
US9174031B2 (en) | 2009-03-13 | 2015-11-03 | Reshape Medical, Inc. | Device and method for deflation and removal of implantable and inflatable devices |
US9358143B2 (en) | 2009-07-22 | 2016-06-07 | Reshape Medical, Inc. | Retrieval mechanisms for implantable medical devices |
US9604038B2 (en) | 2009-07-23 | 2017-03-28 | Reshape Medical, Inc. | Inflation and deflation mechanisms for inflatable medical devices |
US9987470B2 (en) | 2009-07-23 | 2018-06-05 | ReShape Medical, LLC | Deflation and removal of implantable medical devices |
US9622896B2 (en) | 2010-02-08 | 2017-04-18 | Reshape Medical, Inc. | Enhanced aspiration processes and mechanisms for instragastric devices |
US9579226B2 (en) | 2010-02-08 | 2017-02-28 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9149611B2 (en) | 2010-02-08 | 2015-10-06 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9681973B2 (en) | 2010-02-25 | 2017-06-20 | Reshape Medical, Inc. | Enhanced explant processes and mechanisms for intragastric devices |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
US9629740B2 (en) | 2010-04-06 | 2017-04-25 | Reshape Medical, Inc. | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US10117766B2 (en) | 2010-04-06 | 2018-11-06 | Reshape Medical Llc | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US9295573B2 (en) | 2010-04-29 | 2016-03-29 | Apollo Endosurgery, Inc. | Self-adjusting gastric band having various compliant components and/or a satiety booster |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US9192501B2 (en) | 2010-04-30 | 2015-11-24 | Apollo Endosurgery, Inc. | Remotely powered remotely adjustable gastric band system |
US9050165B2 (en) | 2010-09-07 | 2015-06-09 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding system |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
US10070981B2 (en) | 2013-03-15 | 2018-09-11 | Baronova, Inc. | Locking gastric obstruction device and method of use |
US10874538B2 (en) | 2013-03-15 | 2020-12-29 | Baronova, Inc. | Locking gastric obstruction device and method of use |
Also Published As
Publication number | Publication date |
---|---|
AU3873489A (en) | 1990-02-05 |
US4925446A (en) | 1990-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4925446A (en) | Removable inflatable intragastrointestinal device for delivering beneficial agents | |
ES2562236T3 (en) | Intragastric volume occupation device | |
ES2343118T3 (en) | DEVICE THAT OCCUPIES INTRAGASTRIC VOLUME OF AUTOINFLATE. | |
ES2641234T3 (en) | Pyloric valve obstruction device | |
ES2415704T3 (en) | Devices for pyloric anchorage | |
US4485805A (en) | Weight loss device and method | |
ES2653806T3 (en) | Intragastric device | |
US3786813A (en) | Drug delivery device with self actuated mechanism for retaining device in selected area | |
US20080109027A1 (en) | Method and system for gastric volume control | |
CN107913125B (en) | Intragastric device | |
WO2009059803A1 (en) | Externally inflatable gastric balloon device | |
EP3337432B1 (en) | Intragastric device for weight management | |
ES2718500T3 (en) | Intragastric balloon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |